Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation

Br J Haematol. 2012 Mar;156(5):683-6. doi: 10.1111/j.1365-2141.2011.08905.x. Epub 2011 Nov 3.

Authors

Roland Fenk, Florian Neubauer, Ingmar Bruns, Thomas Schröder, Ulrich Germing, Rainer Haas, Guido Kobbe

PMID: 22050384
DOI: 10.1111/j.1365-2141.2011.08905.x

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Hematopoietic Stem Cell Transplantation*
Humans
Middle Aged
Multiple Myeloma / drug therapy*
Neoplasms, Second Primary*
Retrospective Studies